{"created":"2023-06-20T15:52:51.496015+00:00","id":7212,"links":{},"metadata":{"_buckets":{"deposit":"7672ea16-8f86-47b9-bf1d-d34b0f65bf6e"},"_deposit":{"created_by":34,"id":"7212","owners":[34],"pid":{"revision_id":0,"type":"depid","value":"7212"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00007212","sets":["195:197:201"]},"author_link":["25884","25888","25886","25883","25881","25887","25882","25889","25885"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"14","bibliographicPageStart":"9","bibliographicVolumeNumber":"37","bibliographic_titles":[{"bibliographic_title":"松山赤十字病院医学雑誌"}]}]},"item_10002_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"潰瘍性大腸炎の臨床経過を遡及的に検討し、インフリキシマブ(IFX)による寛解導入・寛解維持効果を評価した。①寛解導入目的でIFXを投与した活動期UC49例において単回投与2週間でLichtiger indexは平均9.0から平均5.7に低下し(p<0.0001)、30例(61%)が寛解となった。②IFX単回投与で寛解導入後、維持投与未実施群(IFX単回投与群;n=21)と寛解導入後8週毎の維持投与実施群(IFX維持投与群;n=14)とに分類し、累積寛解維持率を比較した。IFX単回投与群とIFX維持投与群における累積寛解維持率は、それぞれ3ヵ月後で43%、77%、6ヵ月後で24%、39%であり、IFX維持投与群はIFX単回投与群と比較し、有意に累積寛解維持率が高かった(p=0.02)。以上より、IFXはステロイド依存・抵抗性潰瘍性大腸炎に対して、高い寛解導入・寛解維持効果を有すると考えられた。(著者抄録)","subitem_description_type":"Abstract"}]},"item_10002_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0385-3888","subitem_source_identifier_type":"ISSN"}]},"item_10002_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"河内, 修司"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"川崎, 啓祐"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"蔵原, 晃一"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"尾石, 義謙"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"岡本, 康治"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"永田, 豊"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"阿部, 洋文"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"徳本, 真矢"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"渕上, 忠彦"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2015-03-26"}],"displaytype":"simple","filename":"河内先生-144.pdf","filesize":[{"value":"741.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"matsuyama00014","url":"https://redcross.repo.nii.ac.jp/record/7212/files/河内先生-144.pdf"},"version_id":"510d93de-bfa5-4e0e-add5-564de62f5ea1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"ulcerative colitis","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"infliximab","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"induction of remission","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"maintenance of remission","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"当センターにおけるステロイド依存・抵抗性潰瘍性大腸炎に対するインフリキシマブの寛解導入および寛解維持効果の検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"当センターにおけるステロイド依存・抵抗性潰瘍性大腸炎に対するインフリキシマブの寛解導入および寛解維持効果の検討"}]},"item_type_id":"10002","owner":"34","path":["201"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-03-26"},"publish_date":"2015-03-26","publish_status":"0","recid":"7212","relation_version_is_last":true,"title":["当センターにおけるステロイド依存・抵抗性潰瘍性大腸炎に対するインフリキシマブの寛解導入および寛解維持効果の検討"],"weko_creator_id":"34","weko_shared_id":-1},"updated":"2023-06-20T20:14:58.200461+00:00"}